Revenue
2018
2019
2020
2021
2022
2023
2024
2025
WEST PHARMACEUTICAL SERVICES INC (WST)
Price—Loading quote
Net income
2018
2019
2020
2021
2022
2023
2024
2025
Free cash flow
2018
2019
2020
2021
2022
2023
2024
2025
Total cash / debt
CashTotal debt
2018
2019
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $3.07B | $2.89B | $2.95B | $2.89B | $2.83B | $2.15B | $1.84B | $1.72B | $1.60B | $1.51B | $1.40B | $1.42B | $1.37B | $1.27B | $1.19B | $1.10B | $1.06B | $1.05B |
| Gross profit | $1.10B | $998.5M | $1.13B | $1.14B | $1.18B | $767.8M | $605.7M | $545.4M | $512.9M | $501.4M | $455.8M | $447.8M | $434.7M | $387.7M | $339.3M | $318.1M | $303.6M | $302.6M |
| Research & development | $74.3M | $69.1M | $68.4M | $58.5M | $52.8M | $46.9M | $38.9M | $40.3M | $39.1M | $36.8M | $34.1M | $37.3M | $37.9M | $33.2M | $29.1M | $23.9M | $19.9M | $18.7M |
| Operating income | $584.9M | $569.9M | $676.0M | $734.0M | $752.3M | $406.9M | $296.6M | $240.3M | $225.8M | $195.2M | $128.6M | $182.0M | $162.4M | $135.1M | $109.6M | $90.7M | $97.5M | $124.1M |
| EBITDAderived | $756.3M | $725.3M | $813.3M | $854.6M | $874.6M | $516.0M | $400.0M | $344.7M | $322.5M | $285.9M | $218.5M | $272.0M | $247.6M | $212.0M | $185.3M | $163.9M | $165.6M | — |
| Net income | $493.7M | $492.7M | $593.4M | $585.9M | $661.8M | $346.2M | $241.7M | $206.9M | $150.7M | $143.6M | $95.6M | $127.1M | $112.3M | $80.7M | $75.5M | $65.3M | $72.6M | $86.0M |
| Basic EPSper diluted share | $6.83 | $6.75 | $7.98 | $7.87 | $8.89 | $4.68 | $3.27 | $2.80 | $2.04 | $1.96 | $1.33 | $1.79 | $1.61 | $1.19 | $1.12 | $1.96 | $2.21 | $2.65 |
| Diluted EPSper diluted share | $6.79 | $6.69 | $7.88 | $7.73 | $8.67 | $4.57 | $3.21 | $2.74 | $1.99 | $1.91 | $1.30 | $1.75 | $1.57 | $1.15 | $1.08 | $1.89 | $2.12 | $2.50 |
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Apr 27, 2026Form 4 | Favorite Annette FSr. VP & Chief HR Officer | SellCommon Stock | 2.8K | $305.20 | $859.7K | 16.8K |
| Apr 27, 2026Form 4 | Winters ChadVP, Chief Accounting Officer | SellCommon Stock | 896 | $300.67 | $269.4K | 1.5K |
| Oct 29, 2024Form 4 | Witherspoon CharlesVP & Treasurer | SellCommon Stock | 225 | $310.40 | $69.8K | 1.3K |
| Oct 29, 2024Form 4 | Witherspoon CharlesVP & Treasurer | SellCommon Stock | 478 | $310.40 | $148.4K | 1.5K |
| Aug 19, 2024Form 4 | Witherspoon CharlesVP & Treasurer | SellCommon Stock | 500 | $300.00 | $150.0K | 1.5K |